About Pablo Cironi
Pablo Cironi is a director at Tolerance Bio.
Experience
This experience comes from Pablo Cironi's profile and from SEC filings. For roles taken from filings, the years are when the filings name Pablo Cironi in the role, so the role may have started earlier or lasted longer.
CL
Cytospire Therapeutics Ltd Current
Board Observer
2026 – Present
NT
NRG Therapeutics Current
Board Observer
2025 – Present
Tolerance Bio Inc. Current
Director
2024 – Present · Philadelphia, PA
Develops thymus-based therapies for people with immune-mediated diseases.
CV
Criteria Bio Ventures Current
Managing Director
2023 – Present
AP
AbolerIS Pharma Current
Board Member
2023 – Present
AT
Adaptam Therapeutics Current
Chairman of the Board
2023 – Present
CR
Criteria Capital Risc Current
Director of Life Science Investment Funds
2019 – Present
MT
Minoryx Therapeutics Current
Board Member
2019 – Present
ML
MedLumics, S.L.
Board Member
2018 – 2025
AT
AELIX Therapeutics
Board Member
2019 – 2024
GD
GlyCardial Diagnostics
Board Member
2019 – 2023
SA
SANIFIT
Board Member
2019 – 2022
SB
Splice Bio
Board member
2019 – 2022
AP
AptaTargets
Board Member
2019 – 2020
CR
Caixa Capital Risc
Principal
2018 – 2019
CC
Centre for Genomic Regulation (CRG)
Head of the Technology and Business Devlopment Office
2013 – 2018
FN
Fundación Botín
Tecnology Development manager
2009 – 2013
HS
Harvard Medical School
Senior Postdoctoral fellow
2005 – 2009
HU
Harvard University
Postdoctoral fellow
2005 – 2009
FU
Fulbright
Becario
2005 – 2007
Key Colleagues at Startups
The people Pablo Cironi works with at each company, as listed on that company's latest Form D.
Tolerance Bio Inc. · Form D, Jun 18, 2026
Philip Ball
SVP, Head of Business Development and Operations, director
DC
Damia Carulla
Director
Justin Vogel
Chief Financial Officer and director
Francisco Leon
Founder and CEO, director
RG
Robert Goldstein
Director